NEAT1 and B-cell chronic lymphocytic leukemia: Although the analysis has been limited only to the four available patients with del17p, our results showed that neither global NEAT1 nor NEAT1_2 expression levels in CLL were significantly lower than the ones detected in patients without del17p (n = 299; NEAT1 with del17p: 1.067 ± 1.013 vs without del17p 1.628 ± 1.229, p = 0.25; NEAT1_2 with del17p: 2.679 ± 0.557 vs. without del17p 3.154 ± 1.576, p = 0.34).